AstraZeneca
-
AstraZeneca plans to nearly double sales to $80 billion in 2030
British pharmaceutical giant AstraZeneca said on Tuesday that it aims to reach sales of $80 billion by 2030, nearly double from $45.8 billion in 2023.
British pharmaceutical giant AstraZeneca said on Tuesday that it aims to reach sales of $80 billion by 2030, nearly double from $45.8 billion in 2023.